Those eligible for a vaccine can access jabs from the NHS, but experts say that people have turned to pharmacies for ...
Greenwich LifeSciences stock rose after Phase 3 data showed GLSI-100 cut breast cancer recurrence rates by about 80% in new ...
The program that pays people injured by vaccines irks advocates in the Make America Healthy Again movement. RFK says he'll ...
We review the biggest local headlines in health care for 2025 with WBUR senior health reporter Priyanka Dayal McCluskey and Massachusetts League of Community Health Centers' Michael Curry.
Pfizer's COVID-19 vaccine has become the first in the U.S. to receive full approval from the FDA for people ages 16 and up.
Investing.com -- Valneva SE (NASDAQ:VALN) stock gained 3.7% on Thursday after the specialty vaccine company reported positive final Phase 2 antibody persistence and safety results for its chikungunya ...
The contract, awarded by NIH/NIAID, provides up to US $40 million of non-dilutive funding to Vitalex and its collaborator Appili and for the comprehensive development of VXV-01.
Hepatitis B is a viral infection that attacks the liver and can lead to both acute and chronic illness. It can cause ...
Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026. Keep ...
Anixa Biosciences shares surged in after-hours trading after presenting clinical trial data for its investigational breast ...
Zacks Investment Research on MSN
CVS stock gains from offering MMR vaccine to South Carolina residents
CVS Health CVS has recently announced the offering of measles-mumps-rubella (MMR) vaccine to residents post the current outbreak in South Carolina. Both CVS Pharmacy stores and MinuteClinic walk-in ...
Andrew Nixon, HHS spokesperson, confirmed the FDA's investigation of the COVID-19 vaccine revealed in a recently leaked email.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback